Harrow Health Inc (NASDAQ:HROW)

8.64
Delayed Data
As of 3:59pm ET
 +0.10 / +1.17%
Today’s Change
5.40
Today|||52-Week Range
12.99
0.00%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Baum Mark L
Chief Executive Officer
Sale1/20/202271,406$8.33$594.8K+2.04%
Opaleye Management Inc
Buy8/19/202150,000$8.44$422.0K+1.07%
Baum Mark L
Chief Executive Officer
Buy1/20/2022125,000$2.40$300.0K+2.04%
Saharek John P
Sale2/19/202225,923$7.87$204.0K+2.53%
Opaleye Management Inc
Buy4/12/202225,000$6.75$168.8K+26.30%
Boll Andrew R
Chief Financial Officer
Sale2/19/202220,605$7.87$162.2K+2.53%
Lindstrom Richard L
Director
Sale9/15/202114,160$9.09$128.7K-6.08%
Opaleye Management Inc
Buy4/13/202210,000$6.76$67.6K+25.37%
Lindstrom Richard L
Director
Sale9/16/20215,840$9.02$52.7K-7.51%
Lindstrom Richard L
Director
Sale9/24/20213,900$10.04$39.2K-10.43%
Page of 2